Literature DB >> 25194425

Alpha Klotho and phosphate homeostasis.

A Bian1, C Xing, M C Hu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25194425      PMCID： PMC4485939          DOI： 10.1007/s40618-014-0158-6

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  69 in total

1.  Altered distribution of bone matrix proteins and defective bone mineralization in klotho-deficient mice.

Authors:  Muneteru Sasaki; Tomoka Hasegawa; Tamaki Yamada; Hiromi Hongo; Paulo Henrique Luiz de Freitas; Reiko Suzuki; Tomomaya Yamamoto; Chihiro Tabata; Satoru Toyosawa; Tsuneyuki Yamamoto; Kimimitsu Oda; Minqi Li; Nobuo Inoue; Norio Amizuka
Journal:  Bone       Date:  2013-08-14       Impact factor: 4.398

Review 2.  Laboratory abnormalities in CKD-MBD: markers, predictors, or mediators of disease?

Authors:  Pieter Evenepoel; Mariano Rodriguez; Markus Ketteler
Journal:  Semin Nephrol       Date:  2014-02-18       Impact factor: 5.299

3.  Regulation of renal phosphate transport by FGF23 is mediated by FGFR1 and FGFR4.

Authors:  Jyothsna Gattineni; Priyatharshini Alphonse; Qiuyu Zhang; Nisha Mathews; Carlton M Bates; Michel Baum
Journal:  Am J Physiol Renal Physiol       Date:  2013-11-20

4.  Correlation between hyperphosphatemia and type II Na-Pi cotransporter activity in klotho mice.

Authors:  Hiroko Segawa; Setsuko Yamanaka; Yasue Ohno; Akemi Onitsuka; Kazuyo Shiozawa; Fumito Aranami; Junya Furutani; Yuka Tomoe; Mikiko Ito; Masashi Kuwahata; Akihiro Imura; Yoichi Nabeshima; Ken-ichi Miyamoto
Journal:  Am J Physiol Renal Physiol       Date:  2006-09-19

5.  Type II Na+-Pi cotransporters in osteoblast mineral formation: regulation by inorganic phosphate.

Authors:  Patrik Lundquist; Heini Murer; Jürg Biber
Journal:  Cell Physiol Biochem       Date:  2007

6.  A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis.

Authors:  Shoji Ichikawa; Erik A Imel; Mary L Kreiter; Xijie Yu; Donald S Mackenzie; Andrea H Sorenson; Regina Goetz; Moosa Mohammadi; Kenneth E White; Michael J Econs
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

7.  The parathyroid is a target organ for FGF23 in rats.

Authors:  Iddo Z Ben-Dov; Hillel Galitzer; Vardit Lavi-Moshayoff; Regina Goetz; Makoto Kuro-o; Moosa Mohammadi; Roy Sirkis; Tally Naveh-Many; Justin Silver
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

8.  A translocation causing increased alpha-klotho level results in hypophosphatemic rickets and hyperparathyroidism.

Authors:  Catherine A Brownstein; Felix Adler; Carol Nelson-Williams; Junko Iijima; Peining Li; Akihiro Imura; Yo-Ichi Nabeshima; Miguel Reyes-Mugica; Thomas O Carpenter; Richard P Lifton
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-28       Impact factor: 11.205

Review 9.  FGF23 and Klotho in chronic kidney disease.

Authors:  Hannes Olauson; Tobias E Larsson
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-07       Impact factor: 2.894

10.  Fibroblast growth factor 23 enhances renal klotho abundance.

Authors:  Tsuneo Takenaka; Yusuke Watanabe; Tsutomu Inoue; Takashi Miyazaki; Hiromichi Suzuki
Journal:  Pflugers Arch       Date:  2013-03-07       Impact factor: 3.657
View more
  11 in total

1.  Cisplatin nephrotoxicity as a model of chronic kidney disease.

Authors:  Mingjun Shi; Kathryn L McMillan; Junxia Wu; Nancy Gillings; Brianna Flores; Orson W Moe; Ming Chang Hu
Journal:  Lab Invest       Date:  2018-06-01       Impact factor: 5.662

2.  Mineral metabolism abnormalities in patients with prostate cancer: a systematic case controlled study.

Authors:  Francesco Minisola; Cristiana Cipriani; Luciano Colangelo; Mirella Cilli; Alessandro Sciarra; Magnus Von Heland; Luciano Nieddu; Emanuela Anastasi; Roberto Pascone; Valeria Fassino; Daniele Diacinti; Flavia Longo; Salvatore Minisola; Jessica Pepe
Journal:  Endocrine       Date:  2017-06-28       Impact factor: 3.633

3.  Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy.

Authors:  Ming Chang Hu; Mingjun Shi; Nancy Gillings; Brianna Flores; Masaya Takahashi; Makoto Kuro-O; Orson W Moe
Journal:  Kidney Int       Date:  2017-01-25       Impact factor: 10.612

4.  P2X7 receptor and klotho expressions in diabetic nephropathy progression.

Authors:  A M Rodrigues; R S Serralha; C Farias; G R Punaro; M J S Fernandes; Elisa Mieko Suemitsu Higa
Journal:  Purinergic Signal       Date:  2018-03-14       Impact factor: 3.765

Review 5.  αKlotho and Chronic Kidney Disease.

Authors:  J A Neyra; M C Hu
Journal:  Vitam Horm       Date:  2016-03-24       Impact factor: 3.421

6.  Dietary vitamin D interacts with high phosphate-induced cardiac remodeling in rats with normal renal function.

Authors:  Ming Chang Hu; Roberto Scanni; Jianfeng Ye; Jianning Zhang; Mingjun Shi; Jenny Maique; Brianna Flores; Orson W Moe; Reto Krapf
Journal:  Nephrol Dial Transplant       Date:  2020-03-01       Impact factor: 5.992

7.  The tripartite interaction of phosphate, autophagy, and αKlotho in health maintenance.

Authors:  Mingjun Shi; Jenny Maique; Joy Shaffer; Taylor Davidson; Salwa Sebti; Álvaro F Fernández; Zhongju Zou; Shirley Yan; Beth Levine; Orson W Moe; Ming Chang Hu
Journal:  FASEB J       Date:  2020-01-05       Impact factor: 5.191

Review 8.  Klotho/FGF23 Axis in Chronic Kidney Disease and Cardiovascular Disease.

Authors:  Xiang Lu; Ming Chang Hu
Journal:  Kidney Dis (Basel)       Date:  2016-11-17

Review 9.  Role of Bisphosphonates in Vascular calcification and Bone Metabolism: A Clinical Summary.

Authors:  Pradeep Dayanand; Harigopal Sandhyavenu; Sandeep Dayanand; Jasmin Martinez; Janani Rangaswami
Journal:  Curr Cardiol Rev       Date:  2018

10.  In search of alternatively spliced alpha-Klotho Kl1 protein in mouse brain.

Authors:  Liping Li; Johanne Pastor; Jianning Zhang; Taylor Davidson; Ming-Chang Hu; Orson W Moe
Journal:  FASEB Bioadv       Date:  2021-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.